HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...

We've all heard about the amazing benefits of GLP-1 medications in managing weight and blood sugar, but what happens when ...

Highlights of the findings include: Stopping Ozempic three to five days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia. In contrast ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Patients taking GLP-1 drugs also had a 31% lower risk of dying ... She is an associate professor of surgery and population health at NYU Grossman School of Medicine. Orandi said this risk can ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

The U.S. medical weight loss market has skyrocketed, doubling in value to $33.8 billion from 2022 to 2024, fueled by the overwhelming demand for GLP-1 medications like Wegovy and Mounjaro. This latest ...

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...